The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ¿Pharmacy of the World¿ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ¿Innovate in India and Serve to the World¿. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.
| Autorius: | Mithun Nandy |
| Leidėjas: | Springer Nature Singapore |
| Išleidimo metai: | 2021 |
| Knygos puslapių skaičius: | 236 |
| ISBN-10: | 9811669201 |
| ISBN-13: | 9789811669200 |
| Formatas: | Knyga kietu viršeliu |
| Kalba: | Anglų |
| Žanras: | Financial reporting, financial statements |
Parašykite atsiliepimą apie „Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry“
